The clinical and therapeutic implications of cancer stem cell biology

Liang Cheng, Riley Alexander, Shaobo Zhang, Chong Xian Pan, Gregory T. MacLennan, Antonio Lopez-Beltran, Rodolfo Montironi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) have provided new insights into the tumorigenesis and metastatic potential of cancer. The discovery of CSCs has provided many new insights into the complexities of cancer therapy: tumor initiation, treatment resistance, metastasis, recurrence, assessment of prognosis and prediction of clinical course. Recent rapid advances in molecular analysis have contributed to the better understanding of the molecular attributes and pathways that give CSCs their unique attributes. Use of these molecular techniques has facilitated elucidation of specific surface markers and pathways that favor propagation of CSCs - allowing for targeted therapy. Furthermore, it has been discovered that a specific microenvironment, or niche, is essential for the genesis of tumors from CSCs. Therapeutic strategies that alter these microenvironments compromise CSC proliferation and constitute another method of targeted cancer therapy. We review the clinical and therapeutic implications of CSCs, with a focus on treatment resistance and metastasis, and the emerging approaches to target CSCs and their microenvironments in order to attain improved outcomes in cancer. It is noteworthy that CSCs are the only cells capable of sustaining tumorigenesis; however, the cell of origin of cancer, in which tumorigenesis is initiated, may be distinct from CSCs that propagate the tumor.

Original languageEnglish
Pages (from-to)1131-1143
Number of pages13
JournalExpert Review of Anticancer Therapy
Volume11
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Neoplastic Stem Cells
Cell Biology
Neoplasms
Therapeutics
Carcinogenesis
Neoplasm Metastasis
Stem Cell Niche
Cell Proliferation
Recurrence

Keywords

  • cancer stem cell
  • mesenchymal stem cell
  • metastasis
  • pathway targeting
  • personalized medicine
  • targeted therapy
  • tumorigenesis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Cheng, L., Alexander, R., Zhang, S., Pan, C. X., MacLennan, G. T., Lopez-Beltran, A., & Montironi, R. (2011). The clinical and therapeutic implications of cancer stem cell biology. Expert Review of Anticancer Therapy, 11(7), 1131-1143. https://doi.org/10.1586/era.11.82

The clinical and therapeutic implications of cancer stem cell biology. / Cheng, Liang; Alexander, Riley; Zhang, Shaobo; Pan, Chong Xian; MacLennan, Gregory T.; Lopez-Beltran, Antonio; Montironi, Rodolfo.

In: Expert Review of Anticancer Therapy, Vol. 11, No. 7, 07.2011, p. 1131-1143.

Research output: Contribution to journalArticle

Cheng, L, Alexander, R, Zhang, S, Pan, CX, MacLennan, GT, Lopez-Beltran, A & Montironi, R 2011, 'The clinical and therapeutic implications of cancer stem cell biology', Expert Review of Anticancer Therapy, vol. 11, no. 7, pp. 1131-1143. https://doi.org/10.1586/era.11.82
Cheng, Liang ; Alexander, Riley ; Zhang, Shaobo ; Pan, Chong Xian ; MacLennan, Gregory T. ; Lopez-Beltran, Antonio ; Montironi, Rodolfo. / The clinical and therapeutic implications of cancer stem cell biology. In: Expert Review of Anticancer Therapy. 2011 ; Vol. 11, No. 7. pp. 1131-1143.
@article{c96364df65724184adef25982fc27b82,
title = "The clinical and therapeutic implications of cancer stem cell biology",
abstract = "Cancer stem cells (CSCs) have provided new insights into the tumorigenesis and metastatic potential of cancer. The discovery of CSCs has provided many new insights into the complexities of cancer therapy: tumor initiation, treatment resistance, metastasis, recurrence, assessment of prognosis and prediction of clinical course. Recent rapid advances in molecular analysis have contributed to the better understanding of the molecular attributes and pathways that give CSCs their unique attributes. Use of these molecular techniques has facilitated elucidation of specific surface markers and pathways that favor propagation of CSCs - allowing for targeted therapy. Furthermore, it has been discovered that a specific microenvironment, or niche, is essential for the genesis of tumors from CSCs. Therapeutic strategies that alter these microenvironments compromise CSC proliferation and constitute another method of targeted cancer therapy. We review the clinical and therapeutic implications of CSCs, with a focus on treatment resistance and metastasis, and the emerging approaches to target CSCs and their microenvironments in order to attain improved outcomes in cancer. It is noteworthy that CSCs are the only cells capable of sustaining tumorigenesis; however, the cell of origin of cancer, in which tumorigenesis is initiated, may be distinct from CSCs that propagate the tumor.",
keywords = "cancer stem cell, mesenchymal stem cell, metastasis, pathway targeting, personalized medicine, targeted therapy, tumorigenesis",
author = "Liang Cheng and Riley Alexander and Shaobo Zhang and Pan, {Chong Xian} and MacLennan, {Gregory T.} and Antonio Lopez-Beltran and Rodolfo Montironi",
year = "2011",
month = "7",
doi = "10.1586/era.11.82",
language = "English",
volume = "11",
pages = "1131--1143",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "7",

}

TY - JOUR

T1 - The clinical and therapeutic implications of cancer stem cell biology

AU - Cheng, Liang

AU - Alexander, Riley

AU - Zhang, Shaobo

AU - Pan, Chong Xian

AU - MacLennan, Gregory T.

AU - Lopez-Beltran, Antonio

AU - Montironi, Rodolfo

PY - 2011/7

Y1 - 2011/7

N2 - Cancer stem cells (CSCs) have provided new insights into the tumorigenesis and metastatic potential of cancer. The discovery of CSCs has provided many new insights into the complexities of cancer therapy: tumor initiation, treatment resistance, metastasis, recurrence, assessment of prognosis and prediction of clinical course. Recent rapid advances in molecular analysis have contributed to the better understanding of the molecular attributes and pathways that give CSCs their unique attributes. Use of these molecular techniques has facilitated elucidation of specific surface markers and pathways that favor propagation of CSCs - allowing for targeted therapy. Furthermore, it has been discovered that a specific microenvironment, or niche, is essential for the genesis of tumors from CSCs. Therapeutic strategies that alter these microenvironments compromise CSC proliferation and constitute another method of targeted cancer therapy. We review the clinical and therapeutic implications of CSCs, with a focus on treatment resistance and metastasis, and the emerging approaches to target CSCs and their microenvironments in order to attain improved outcomes in cancer. It is noteworthy that CSCs are the only cells capable of sustaining tumorigenesis; however, the cell of origin of cancer, in which tumorigenesis is initiated, may be distinct from CSCs that propagate the tumor.

AB - Cancer stem cells (CSCs) have provided new insights into the tumorigenesis and metastatic potential of cancer. The discovery of CSCs has provided many new insights into the complexities of cancer therapy: tumor initiation, treatment resistance, metastasis, recurrence, assessment of prognosis and prediction of clinical course. Recent rapid advances in molecular analysis have contributed to the better understanding of the molecular attributes and pathways that give CSCs their unique attributes. Use of these molecular techniques has facilitated elucidation of specific surface markers and pathways that favor propagation of CSCs - allowing for targeted therapy. Furthermore, it has been discovered that a specific microenvironment, or niche, is essential for the genesis of tumors from CSCs. Therapeutic strategies that alter these microenvironments compromise CSC proliferation and constitute another method of targeted cancer therapy. We review the clinical and therapeutic implications of CSCs, with a focus on treatment resistance and metastasis, and the emerging approaches to target CSCs and their microenvironments in order to attain improved outcomes in cancer. It is noteworthy that CSCs are the only cells capable of sustaining tumorigenesis; however, the cell of origin of cancer, in which tumorigenesis is initiated, may be distinct from CSCs that propagate the tumor.

KW - cancer stem cell

KW - mesenchymal stem cell

KW - metastasis

KW - pathway targeting

KW - personalized medicine

KW - targeted therapy

KW - tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=79961074389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961074389&partnerID=8YFLogxK

U2 - 10.1586/era.11.82

DO - 10.1586/era.11.82

M3 - Article

C2 - 21806335

AN - SCOPUS:79961074389

VL - 11

SP - 1131

EP - 1143

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 7

ER -